2023
Post-COVID Syndrome and Cardiorespiratory Fitness-26-Month Experience of Single Center
SOVA, Milan, Eliska SOVOVA, Jaromir OZANA, Katarina MORAVCOVA, Marketa SOVOVA et. al.Základní údaje
Originální název
Post-COVID Syndrome and Cardiorespiratory Fitness-26-Month Experience of Single Center
Autoři
SOVA, Milan (203 Česká republika, domácí), Eliska SOVOVA (203 Česká republika), Jaromir OZANA (203 Česká republika), Katarina MORAVCOVA (203 Česká republika), Marketa SOVOVA (203 Česká republika), Libor JELINEK (203 Česká republika), Jan MIZERA (203 Česká republika) a Samuel GENZOR (203 Česká republika, garant)
Vydání
LIFE-BASEL, BASEL, MDPI, 2023, 2075-1729
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30203 Respiratory systems
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.200 v roce 2022
Kód RIV
RIV/00216224:14110/23:00130752
Organizační jednotka
Lékařská fakulta
UT WoS
000958163800001
Klíčová slova anglicky
post-COVID syndrome; cardiopulmonary exercise testing
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 5. 2023 14:23, Mgr. Tereza Miškechová
Anotace
V originále
Introduction: Persistent post-COVID syndrome, also referred to as long COVID, is a pathologic entity that involves persistent physical, medical, and cognitive sequelae following COVID-19. Decreased fitness has repeatedly been reported in numerous studies dealing with post-COVID syndrome, however, it is still not fully clear which groups of patients may be more susceptible for persisting symptoms. Aim: The aim of our study was to evaluate the number of post-COVID patients with cardiac symptoms, where these patients were evaluated by CPET and the results compared with a control group of patients. Methods: Follow-up of patients in post-COVID outpatient clinic from 1 March 2020 to 31 May 2022. Inclusion criteria were positive PCR test for SARS-CoV-2 and age 18-100. The initial examination was performed 4-12 weeks after the disease onset. All patients with possible cardiac symptoms had completed cardiopulmonary exercise testing. The control group was randomly selected from a database of clients in 2019, with the preventive reason for evaluation. Results: From 1 March 2020 to 31 May 2022, 2732 patients (45.7% males) were evaluated with a mean age of 54.6 +/- 14.7. CPET was indicated only in 97 patients (3.5%). Seventy-four patients (26 male) achieved the exercise maximum and a comparison were made with a control group (same age (p = 0.801), BMI (p = 0.721), and sex ratio). No significant dependence between the parameter VO2 max mL/kg/min and post-COVID disability was demonstrated (p = 0.412). Spearman's correlation analysis did not show a significant relationship between the parameter VO2 max mL/kg/min and the severity of COVID-19 (p = 0.285). Conclusions: Cardiac symptoms occurred in only a small percentage of patients in our study. There is a need for further studies that would objectively evaluate the effect of COVID-19 disease on the patient's health.